Richard Epstein, Apr 19, 2007
This paper gives a brief analysis of the role of contingent commissions in insurance markets. These contracts have received a great deal of attention in recent years because they were the focal point of major criminal enforcement actions that New York´s then-Attorney General, now Governor, Eliot Spitzer, brought against prominent insurance brokers, including the largest three brokers: Marsh & McLennan, Aon, and Willis. Those prosecutions resulted in fines and other sanctions being lodged against these brokerage houses, as well as continuing criminal prosecution against employees who were engaged in some bid-rigging schemes. On balance, a strong case can be made out for requiring disclosure of contingent commissions and for banning any form of bid-rigging. The adverse consequences of nondisclosures are more difficult to track than those for collusion, given the difficulty of showing in individual cases a connection between the nondisclosure and any pecuniary loss sustained by the insured. The case for banning all contingent commissions in the absence of concealment or bid-rigging, still remains not proven. It is not easy to come up with a powerful efficiency explanation for the use of contingent commission agreements, but if these agreements continue to be adopted with full disclosure in the absence of collusion, then it seems premature to ban them just because our incomplete knowledge of how brokerage markets work does not supply a compelling efficiency justification for their use.
Featured News
Judge Pushes for Faster Pace in NASCAR Antitrust Trial
Dec 8, 2025 by
CPI
Trump Plans Executive Order This Week to Squelch State AI Regulations
Dec 8, 2025 by
CPI
US President Raises Antitrust Worries Over Netflix–Warner Bros. Deal
Dec 8, 2025 by
CPI
Freshfields Adds Former DOJ Antitrust Leader as Partner in San Francisco
Dec 8, 2025 by
CPI
Appeals Court Lifts Injunction, Allowing Florida to Enforce Social Media Age Restriction Law
Dec 8, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Intellectual Property
Nov 19, 2025 by
CPI
Dealing in Intellectual Property: IP Justifications and Defenses in Digital Markets Cases
Nov 19, 2025 by
Jennifer Dixton
The Evolving Role of Innovation Theories of Harm in the Antitrust Analysis of Life Science Mergers
Nov 19, 2025 by
Michelle Yost Hale, Matthew D. McDonald & Merrill Stovroff
Who Can Fix It? Antitrust, IP Rights, and the Right to Repair
Nov 19, 2025 by
Rosa M. Morales
Copyright, Antitrust, and the Politics of Generative AI
Nov 19, 2025 by
Daryl Lim